Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2025-04-08 00:00:00 ET · period of report 2025-04-04 · accession 0000950170-25-052047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-08 | 2025-04-04 | LAB | Egholm Michael | Pres, CEO, Dir | M - OptEx | $0.00 | +196.5K | 2.83M | +7% | $0 |
| D | 2025-04-08 | 2025-04-04 | LAB | Egholm Michael | Pres, CEO, Dir | F - Tax | $1.07 | -57.7K | 2.77M | -2% | -$61.7K |
| D | 2025-04-08 | 2025-04-04 | LAB | Egholm Michael | Pres, CEO, Dir | M - OptEx | $0.00 | -196.5K | 196.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-04 | M | A | 196,512 | $0.00 | 2,832,518 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-04 | F | D | 57,676 | $1.07 | 2,774,842 | D | — | — | (F1) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022. |
| 3 | Derivative | Restricted Stock Units | 2025-04-04 | M | D | 196,512 | $0.00 | 196,513 | D | — · — to — | 196,512 Common Stock | (F2) Each RSU represents the contingent right to receive one share of the Issuer's common stock. (F3) On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023. |